Greenline Partners, LLC Amgen Inc Transaction History

Greenline Partners, LLC

$657 Million
Q2 2024

A detailed history of Greenline Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Greenline Partners, LLC holds 15,555 shares of AMGN stock, worth $4.93 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

15,555

Previous 18,894 17.67%

Holding current value

$4.93 Million

Previous $5.37 Million 9.51%

% of portfolio

0.74%

Previous 0.86%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $877,322 - $1.07 Million	-3,339 Reduced 17.67%	15,555 $4.86 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $29,140 - $34,458	-136 Reduced 0.71%	18,894 $4.19 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $68,192 - $75,439	-311 Reduced 1.61%	19,030 $4.6 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $167,476 - $185,803	-717 Reduced 3.57%	19,341 $4.71 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $429,730 - $511,732	1,986 Added 10.99%	20,058 $4.61 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2.79 Million - $3.1 Million	11,879 Added 191.81%	18,072 $4.59 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $155,874 - $191,279	-788 Reduced 11.29%	6,193 $1.46 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $134,310 - $178,132	-737 Reduced 9.55%	6,981 $1.42 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $236,323 - $303,756	-1,249 Reduced 13.93%	7,718 $1.86 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $13,058 - $15,646	75 Added 0.84%	8,967 $1.74 Million
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $1.99 Million - $2.34 Million	-11,950 Reduced 57.34%	8,892 $1.64 Million
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $4.51 Million - $5.09 Million	-24,956 Reduced 54.49%	20,842 $3.96 Million
Q3 2018 Oct 15, 2018	SELL	$185.29 - $208.89 $233,280 - $262,992	-1,259 Reduced 2.68%	45,798 $9.55 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $334,424 - $375,631	2,014 Added 4.47%	47,057 $8.68 Million
Q1 2018 Jun 21, 2018	BUY	$169.43 - $198.0 $305,312 - $356,796	1,802 Added 4.17%	45,043 $7.68 Million
Q4 2017 Jun 21, 2018	BUY	$168.79 - $188.59 $7.3 Million - $8.15 Million	43,241	43,241 $7.52 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenline Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenline Partners, LLC with notifications on news.

Account

Greenline Partners, LLC Amgen Inc Transaction History